CH25H and Alzheimer disease: RIPK1 activation has been shown to regulate the expression of the Ch25h (cholesterol 25-hydroxylase) gene, one of the lipid metabolism-related genes, in microglia of two animal models of AD, and it positively correlates with Braak staging of the disease.